Page 1916 - Saunders Comprehensive Review For NCLEX-RN
P. 1916

Rationale: Cholinergic overdose of bethanechol chloride produces manifestations
               of excessive muscarinic stimulation such as salivation, sweating, involuntary
               urination and defecation, bradycardia, and severe hypotension. Remember that the
               sympathetic nervous system speeds the heart rate and the cholinergic
               (parasympathetic) nervous system slows the heart rate. Treatment includes
               supportive measures and the administration of atropine sulfate (anticholinergic)
               subcutaneously or intravenously.
                  Test-Taking Strategy: Focus on the subject, signs of cholinergic overdose. Noting
               that options 1, 2, and 4 are comparable or alike will assist in eliminating these
               options.
                  Level of Cognitive Ability: Analyzing
                  Client Needs: Physiological Integrity
                  Integrated Process: Nursing Process—Assessment
                  Content Area: Pharmacology: Renal and Urinary Medications: Cholinergics
                  Health Problem: N/A
                  Priority Concepts: Elimination; Safety
                  Reference: Lilley et al. (2017), pp. 327-328.


                   668. Answer: 4


                  Rationale: Toxicity (overdosage) of oxybutynin produces central nervous system
               excitation, such as nervousness, restlessness, hallucinations, and irritability. Other
               signs of toxicity include hypotension or hypertension, confusion, tachycardia,
               flushed or red face, and signs of respiratory depression. Drowsiness is a frequent
               side effect of the medication but does not indicate overdosage.
                  Test-Taking Strategy: Focus on the subject, signs of toxicity (overdosage) of
               oxybutynin. Remember that restlessness is a sign of toxicity.
                  Level of Cognitive Ability: Analyzing
                  Client Needs: Physiological Integrity
                  Integrated Process: Nursing Process—Assessment
                  Content Area: Pharmacology: Renal and Urinary Medications:
               Anticholinergics/antispasmodics
                  Priority Concepts: Clinical Judgment; Safety
                  Health Problem: N/A
                  Reference: Hodgson, Kizior (2018), pp. 874-875.


                   669. Answer: 3


                  Rationale: Cyclosporine is an immunosuppressant. Nephrotoxicity can occur from
               the use of cyclosporine. Nephrotoxicity is evaluated by monitoring for elevated
               blood urea nitrogen and serum creatinine levels. The normal blood urea nitrogen
               level is 10 to 20 mg/dL (3.6 to 7.1 mmol/L). The normal creatinine level for a male is
               0.6 to 1.2 mg/dL (53 to 106 mcmol/L) and for a female is 0.5 to 1.1 mg/dL (44 to 97
               mcmol/L). Cyclosporine can lower complete blood cell count levels. A normal
               hemoglobin is 14 to 18 g/dL (140 to 180 mmol/L) for a male and 12 to 16 g/dL (120 to
               160 mmol/L) for a female. A normal hemoglobin is not an adverse effect.
               Cyclosporine does affect the glucose level. The normal fasting glucose is 70 to 99



                                                         1916
   1911   1912   1913   1914   1915   1916   1917   1918   1919   1920   1921